These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9038861)

  • 1. Mechanisms of centrally administered ET-1-induced increases in systemic arterial pressure and AVP secretion.
    Rossi NF; O'Leary DS; Chen H
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E126-32. PubMed ID: 9038861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 in hypertension in the baroreflex-intact SHR: a role independent from vasopressin release.
    Rossi NF; O'Leary DS; Woodbury D; Chen H
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E18-24. PubMed ID: 10893318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
    Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
    Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PVN lesions prevent the endothelin 1-induced increase in arterial pressure and vasopressin.
    Rossi NF; Chen H
    Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E349-56. PubMed ID: 11158940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
    Janiak P; Kasson BG; Brody MJ
    Hypertension; 1989 Jun; 13(6 Pt 2):935-40. PubMed ID: 2737730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA agonists inhibit central sodium-induced vasopressin-dependent increases in arterial pressure.
    Brennan TJ; Morris M; Haywood JR
    Eur J Pharmacol; 1984 Aug; 103(3-4):223-34. PubMed ID: 6489442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system.
    Qadri F; Bäurle L; Häuser W; Rascher W; Dominiak P
    J Hypertens; 1999 Sep; 17(9):1265-71. PubMed ID: 10489103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of circulating vasopressin on arterial pressure regulation in rats.
    Pawloski CM; Eicker NM; Ball LM; Mangiapane ML; Fink GD
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H209-18. PubMed ID: 2568756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ganglionic blockers to assess neurogenic pressor activity in conscious rats.
    Santajuliana D; Hornfeldt BJ; Osborn JW
    J Pharmacol Toxicol Methods; 1996 Feb; 35(1):45-54. PubMed ID: 8645881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the cardiovascular responses to intrathecal vasopressin administration in rats.
    Riphagen CL; Pittman QJ
    Can J Physiol Pharmacol; 1989 Apr; 67(4):269-75. PubMed ID: 2758369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vasopressin and the sympathetic nervous system in the cardiovascular response to vagal cold block in the conscious dog.
    Hasser EM; Haywood JR; Johnson AK; Bishop VS
    Circ Res; 1984 Oct; 55(4):454-62. PubMed ID: 6148158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
    Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of renal sympathetic activity and heart rate by vasopressin in hemorrhaged diabetes insipidus rats.
    Peuler JD; Schmid PG; Morgan DA; Mark AL
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H706-12. PubMed ID: 2316685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baroreceptor denervation profoundly enhances cardiovascular responses to central angiotensin II.
    Barron KW; Trapani AJ; Gordon FJ; Brody MJ
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H314-23. PubMed ID: 2568757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
    Thornhill J; Gregor L; Pittman Q
    Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
    Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.